NewslettersHepatic Cell News US FDA Approves First Drug for Fatty Liver Disease NASH By lbeveridge - March 15, 2024 0 The US FDA has approved Madrigal Pharmaceuticals’ drug for a fatty liver disease known as non-alcoholic steatohepatitis (NASH), the first treatment to get the nod for the condition and opening up a multi-billion dollar opportunity. [Reuters] Press Release